UnitedHealth Group Incorporated $UNH Shares Newly Acquired by HBW Advisory Services LLC

HBW Advisory Services LLC purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 9,195 shares of the healthcare conglomerate’s stock, valued at approximately $3,375,000.

Other institutional investors have also modified their holdings of the company. Nalls Sherbakoff Group LLC bought a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $27,000. Wellington Altus USA Inc. lifted its position in UnitedHealth Group by 97.1% during the second quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 33 shares during the last quarter. Lifetime Wealth Management P.C. acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $29,000. Security National Bank of SO Dak purchased a new position in UnitedHealth Group in the second quarter worth $29,000. Finally, Aberdeen Wealth Management LLC acquired a new position in shares of UnitedHealth Group during the second quarter worth $31,000. 87.86% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.19% of the company’s stock.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

  • Positive Sentiment: UnitedHealth reported adjusted earnings of $4.69 per share, above the approximately $4.14 consensus estimate, while revenue of $112.7 billion also exceeded expectations. Operating earnings increased 52% to $6.6 billion, supporting confidence in the company’s turnaround. UnitedHealth Group Shares Gap Up Following Strong Earnings
  • Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $20.50 per share, above its prior $19.50-to-$20.00 range and analyst expectations. The company also indicated that 2027 growth could be stronger than current Wall Street forecasts. UnitedHealth Group Stock Jumps on Profit Outlook Raise
  • Positive Sentiment: Improved medical cost management helped the medical care ratio reach 88.4%. Investors were encouraged by better profitability across UnitedHealthcare and Optum, as well as management’s expectation that Medicaid margins will begin improving after 2026. UnitedHealth Group Gains After Q3 Beat and Higher Outlook
  • Positive Sentiment: Analyst sentiment remains broadly constructive. Piper Sandler raised its target to $504 and maintained an overweight rating, while Mizuho named UNH a top healthcare pick; several targets imply substantial upside from recent levels. UnitedHealth Stock Moves Higher

UnitedHealth Group Trading Up 4.8%

Shares of UnitedHealth Group stock opened at $396.02 on Thursday. The firm’s 50 day simple moving average is $387.10 and its two-hundred day simple moving average is $383.47. The firm has a market capitalization of $355.46 billion, a price-to-earnings ratio of 22.62, a PEG ratio of 1.41 and a beta of 0.60. UnitedHealth Group Incorporated has a 12-month low of $255.96 and a 12-month high of $461.62. The company has a current ratio of 0.74, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping the consensus estimate of $4.14 by $0.55. The business had revenue of $112.70 billion during the quarter, compared to the consensus estimate of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business’s revenue for the quarter was down .4% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Analysts predict that UnitedHealth Group Incorporated will post 20.00 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were given a dividend of $2.32 per share. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group’s payout ratio is currently 59.72%.

Wall Street Analyst Weigh In

UNH has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $370.00 to $467.00 and gave the company a “hold” rating in a report on Friday, July 17th. Oppenheimer boosted their target price on UnitedHealth Group from $420.00 to $500.00 and gave the stock an “outperform” rating in a research note on Friday, July 17th. Truist Financial upped their target price on UnitedHealth Group from $440.00 to $480.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Jefferies Financial Group increased their price target on UnitedHealth Group from $401.00 to $490.00 and gave the company a “buy” rating in a research note on Friday, July 17th. Finally, Sanford C. Bernstein reissued an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday. Twenty research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $461.83.

Get Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.